{
    "2018-03-12": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Genomic Health Hits its Inflection Point",
                "features": {
                    "keywords": [
                        "Genomic",
                        "Health",
                        "Inflection Point"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "The 1 Big Risk That Every Drugmaker Fears",
                "features": {
                    "keywords": [
                        "Big Risk",
                        "Drugmaker",
                        "Fears"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}